Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Hemispherx Bio up 22% on Ampligen + Keytruda studies: SeekingAlpha
BiotechStocktrader
-
January 16, 2019
0
Citius Pharma up 7% on in-license of anti-infective gel wrap
BiotechStocktrader
-
January 9, 2019
0
Hemispherx Biopharma Inc. Announces First Large Ampligen Shipment to a Clinical Site for Use in U.S. Expanded Access Program
BiotechStocktrader
-
December 19, 2018
0
Uncategorized
Home
Uncategorized
Page 3
Uncategorized
Hemispherx $HEB Ampligen May Offer Solution for Universal Flu Vaccine
BiotechStocktrader
-
February 20, 2018
0
Uncategorized
Citius Pharmaceutical $CTXR Mino-Lok™ Phase 3 Clinical Trial Ready
BiotechStocktrader
-
February 5, 2018
0
Uncategorized
Hemispherx $HEB Going After Multi-Billion Dollar Immuno-Oncology Market
BiotechStocktrader
-
January 2, 2018
0
Uncategorized
Hemispherx $HEB Ramping Up Manufacturing to Pursue Multi-Billion Dollar Immuno-Oncology Market
BiotechStocktrader
-
November 3, 2017
0
1
2
3
Page 3 of 3
- Advertisement -
LATEST NEWS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Paul Archie
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva...
Paul Archie
-
December 8, 2020
LATEST INTERVIEWS
